Viral N. Shah, MD
Professor of Medicine, Division of Endocrinology & Metabolism
Indiana University School of Medicine
Featured in the Session: Clinical Algorithm for the Identification, Monitoring, and Management of Elevated Ketones in Ambulatory Settings
When
Friday, June 5
at 5:30 p.m.
Where
220 (Level 2)
Ernest N. Morial Convention Center
What is your presentation about?
During this session, we will be presenting a recent American Diabetes Association® (ADA) consensus on a clinical algorithm for the identification, monitoring, and management of elevated ketones in people with diabetes.
How do you hope your presentation will impact diabetes research or care?
During this session, we will be discussing this new ADA consensus on how to detect elevated ketones and manage it outside hospitals, promoting earlier intervention and clearer thresholds for clinical action. The consensus supports patient education and use of ketone testing, including continuous ketone monitoring (CKM) once it’s available, and proactive self-management when it’s possible, aiming to reduce diabetic ketoacidosis (DKA), especially among high-risk groups such as sodium-glucose cotransporter-2 (SGLT2) inhibitor users and people with type 1 diabetes.
How did you become involved with this area of diabetes research or care?
I have been involved in diabetes research for the past 14 years, with a focus on clinical trials of emerging technologies and therapeutics. While there has been remarkable progress in diabetes care, DKA remains a leading cause of hospitalization and is associated with significant morbidity and suboptimal outcomes. I am honored to serve as chair of the ADA consensus on ketone monitoring and management, and I am confident this work will support healthcare professionals in the early recognition and management of elevated ketones, ultimately helping to prevent DKA.